Nucor, Sabra Health Care And A Major Investment Bank: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has a 9% yield and 5% earnings growth.

Deutsche Bank analyst Omotayo Okusanya initiated coverage on Sabra Health Care REIT with a Buy rating and announced a price target of $21. Sabra Health Care recently named Jessica Flores as executive vice president and chief accounting officer.

Josh Brown of Ritholtz Wealth Management picked The Goldman Sachs Group, Inc. (NYSE: GS). It looks like a breakout is in progress, he added.

On Tuesday, Morgan Stanley analyst Betsy Graseck upgraded Goldman Sachs from Equal-Weight to Overweight and raised the price target from $333 to $449. Oppenheimer analyst Chris Kotowski maintained the stock with an Outperform and raised the price target from $491 to $506.

Don’t forget to check out our premarket coverage here

Joe Terranova of Virtus Investment Partners named Nucor Corporation (NYSE: NUE), which reported upbeat quarterly earnings on Monday.

Nucor reported fourth-quarter earnings of $3.16 per share, which topped analyst estimates of $2.87 per share. Quarterly sales of $7.70 billion clocked in above analyst expectations of $7.65 billion, an 11.74% decrease over sales of $8.72 billion from the same period last year.

Price Action:

• Sabra Health Care shares gained 0.7% to close at $13.58 on Tuesday.
• Shares of Goldman Sachs rose 1.7% to close at $386.87 on Tuesday.
• Nucor shares gained 6.9% to settle at $188.90 during Tuesday’s session.

Check This Out: Insiders Buying Compass Minerals International And 2 Other Stocks

Photo: Shutterstock